Bonte SA
0.9 FTEBonte reported total assets of 929,758 € at the end of the 2025 financial year (annual accounts filed with the NBB on 20 Mar 2026), with 0.9 full-time equivalent.
The score of Bonte shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -3 % Total assets -4 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Bonte's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 46,534 € | ||||
| Equity | 421,390 € | ||||
| Cash | 131,793 € | ||||
| EBITDA | 146,203 € | ||||
| Total assets | 929,758 € |
Filed annual accounts
- Year ended 30 Sep 2025filed on 20 Mar 2026
- Year ended 30 Sep 2024filed on 15 Apr 2025
- Year ended 30 Sep 2023filed on 29 Mar 2024
- Year ended 30 Sep 2022filed on 18 Apr 2023
- Year ended 30 Sep 2021filed on 24 Feb 2022
Bonte's financial analysis
- Solvency45.3%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Bonte
Bonte's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0418.755.334
- VAT number
- BE0418755334
- Peppol
- Registered · 0208:0418755334 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 19 Sep 1978
- Registered office
- 8790 Waregem
- Size
- Micro · 0.9 FTE
- Latest accounts
- 2025 · filed on 20 Mar 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Bonte (SA) has been based in Waregem since 1978, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 46,534 € and equity of 421,390 €; its revenue is not published. With 0.9 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 45.3%, above the median of its sector (44.2%).
Companies similar to Bonte
Companies in the same business, of comparable size and area, outside its group.
- Farmacon Retail sale of pharmaceutical products Lokeren · balance sheet 929,902 €
- Apotheek L. Horsten Retail sale of pharmaceutical products Hoogstraten · balance sheet 929,410 €
- Apoteek VAN DER Sypt Retail sale of pharmaceutical products Beerse · balance sheet 929,004 €
- Pharmacie des Templiers Retail sale of pharmaceutical products Nandrin · balance sheet 928,917 €
- Meurant Retail sale of pharmaceutical products Mons · balance sheet 928,752 €
- Isaphar Retail sale of pharmaceutical products Saint-Ghislain · balance sheet 928,025 €
- EL Rass Retail sale of pharmaceutical products Schaerbeek · balance sheet 925,904 €
- Pharma 4 Retail sale of pharmaceutical products Brussels · balance sheet 925,772 €
Frequently asked questions about Bonte
What is the revenue of Bonte?
Bonte files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Bonte?
In Belgium, the VAT number is the company number prefixed with BE: BE0418755334 for Bonte, if the company is VAT-registered. Its company number (CBE) is 0418.755.334.
Where is the registered office of Bonte?
According to the CBE register, the registered office of Bonte is in 8790 Waregem.
What is the equity of Bonte?
At the close of the 2025 financial year, the equity of Bonte amounts to 421,390 €, a solvency of 45.3% of total assets.
How many people work at Bonte?
0.9 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Bonte?
The register lists 5 active mandates at Bonte. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Bonte
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →